The global biosimilars market is expected to reach $6.22 Billion 1

Biosimilars Market
worth $6.22 Billion
by 2020.
Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim,
Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EP O),
Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood
Disorders.